Biohippo Partners with LipExoGen: Enhancing Research Through Collaboration.
Biohippo is excited to announce our collaboration with LipExoGen, a significant step forward in supporting the scientific community. LipExoGen is a key player in supporting drug development, immunology and immunotherapy, oncology and chemotherapy, and the development of tumor models. This partnership will benefit our customers by advancing their research and development.
About Our Partner, LipExoGen
LipExoGen is a company specializing in a range of biotechnology products and services, primarily focused on liposome, exosome, and gene-related applications. They offer various products including Lentiviral Particles, Liposomal Particles, Lipid Nanoparticles (LNPs), Exosomes and Plasmids. The lentiviral particles cover a range of applications such as TF reporter, shRNA, miRNA, and fluorescence and luciferase dual reporter lentiviruses, etc.
In terms of services, LipExoGen offers extensive options including recombinant antibody services, lipid nanoparticles (LNPs) synthesis, liposome synthesis, peptide synthesis, and a range of gene services like custom lentiviral particles and gene cloning. They also specialize in exosome services, including isolation and engineering.
A significant part of their work is in liposomal formulation development, where they offer a variety of nano formulation services for preclinical research. This includes the development of liposomes, LNPs, solid lipid nanoparticles (SLNs), micelles, and polymeric nanoparticles. Their expertise is quite broad, encompassing the encapsulation of mRNA, small molecules, peptides, proteins, and other bioactive molecules into nanocarriers.
Our Collaboration Focus
Through this collaboration, we're highlighting several key products that are crucial for research:
- • TF Reporter Lentiviral Particles: For studying transcription factor activity, essential in gene expression research.
- • Liposomes: Nanocarriers used in drug delivery and therapeutic applications.
- • Lipid Nanoparticles (LNPs) Synthesis: Advanced technology used in gene therapy for the delivery of nucleic acid-based therapeutics.
- • shRNA Lentiviral Particles: Tools for gene silencing research, aiding in understanding gene function and regulation.
- • Fluorescence and Luciferase Dual Reporter Lentivirus: For monitoring gene expression and cellular events, providing dual-reporting for more accurate data.
Direct Contact for Product Inquiries
While we are updating our website with these new products, we invite our customers to contact us directly with any questions or interest in these products. Your involvement is important to us, and we are ready to provide all the necessary information and support.
Get in Touch with Biohippo
Please feel free to contact us at Biohippo for more details about our collaboration, products, and how we can assist you with your research.
This entry was posted in News and Events